Added benefit of sucroferric oxyhydroxide is not proven

Patients were not treated in compliance with the approval in the two studies presented, which resulted in under- or overdosing. The study data were therefore unsuitable. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *